Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
1988 1
1989 2
1991 2
1992 1
1993 2
1994 3
1995 5
1996 4
1997 4
1998 6
2000 1
2003 3
2004 10
2005 2
2006 5
2007 4
2008 7
2009 6
2011 3
2012 2
2013 1
2015 3
2016 1
2018 2
2019 3
2020 3
2021 2
2023 0

Text availability

Article attribute

Article type

Publication date

Search Results

81 results

Results by year

Filters applied: . Clear all
Page 1
Painful purinergic receptors.
Donnelly-Roberts D, McGaraughty S, Shieh CC, Honore P, Jarvis MF. Donnelly-Roberts D, et al. J Pharmacol Exp Ther. 2008 Feb;324(2):409-15. doi: 10.1124/jpet.106.105890. Epub 2007 Nov 27. J Pharmacol Exp Ther. 2008. PMID: 18042830 Review.
Therapeutic Potential of α7 Nicotinic Acetylcholine Receptors.
Bertrand D, Lee CH, Flood D, Marger F, Donnelly-Roberts D. Bertrand D, et al. Among authors: donnelly roberts d. Pharmacol Rev. 2015 Oct;67(4):1025-73. doi: 10.1124/pr.113.008581. Pharmacol Rev. 2015. PMID: 26419447 Review.
Comparative pharmacology of human dopamine D(2)-like receptor stable cell lines coupled to calcium flux through Galpha(qo5).
Moreland RB, Nakane M, Donnelly-Roberts DL, Miller LN, Chang R, Uchic ME, Terranova MA, Gubbins EJ, Helfrich RJ, Namovic MT, El-Kouhen OF, Masters JN, Brioni JD. Moreland RB, et al. Among authors: donnelly roberts dl. Biochem Pharmacol. 2004 Aug 15;68(4):761-72. doi: 10.1016/j.bcp.2004.05.019. Biochem Pharmacol. 2004. PMID: 15276084
Development of Orally Efficacious Allosteric Inhibitors of TNFα via Fragment-Based Drug Design.
Dietrich JD, Longenecker KL, Wilson NS, Goess C, Panchal SC, Swann SL, Petros AM, Hobson AD, Ihle D, Song D, Richardson P, Comess KM, Cox PB, Dombrowski A, Sarris K, Donnelly-Roberts DL, Duignan DB, Gomtsyan A, Jung P, Krueger AC, Mathieu S, McClure A, Stoll VS, Wetter J, Mankovich JA, Hajduk PJ, Vasudevan A, Stoffel RH, Sun C. Dietrich JD, et al. Among authors: donnelly roberts dl. J Med Chem. 2021 Jan 14;64(1):417-429. doi: 10.1021/acs.jmedchem.0c01280. Epub 2020 Dec 30. J Med Chem. 2021. PMID: 33378180
Novel and potent 3-(2,3-dichlorophenyl)-4-(benzyl)-4H-1,2,4-triazole P2X7 antagonists.
Carroll WA, Kalvin DM, Perez Medrano A, Florjancic AS, Wang Y, Donnelly-Roberts DL, Namovic MT, Grayson G, Honoré P, Jarvis MF. Carroll WA, et al. Among authors: donnelly roberts dl. Bioorg Med Chem Lett. 2007 Jul 15;17(14):4044-8. doi: 10.1016/j.bmcl.2007.04.075. Epub 2007 Apr 27. Bioorg Med Chem Lett. 2007. PMID: 17482819
81 results